Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Rubin Lab
Explore this Website
Home
News
About Us
Research
Lab Team
Publications
Resources
Toggle Resources menu options
FISH
Profiler
Tracking Samples
Weill Cornell Medicine
Care
Discover
Teach
Home
News
About Us
Research
Lab Team
Publications
Resources
Home
Publications
Publications
Found 13 results
Author
Title
Type
Year
Filters:
First Letter Of Title
is
P
[Clear All Filters]
2017
Pauli C
,
Hopkins BD
,
Prandi D
,
Shaw R
,
Fedrizzi T
,
Sboner A
,
Sailer V
,
Augello M
,
Puca L
,
Rosati R
et al.
. 2017.
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.
.
Cancer Discov.
Imielinski M
,
Rubin MA
. 2017.
Prostate cancer: Clinical hallmarks in whole cancer genomes.
.
Nat Rev Clin Oncol.
2016
Evans JR
,
Zhao SG
,
S Chang L
,
Tomlins SA
,
Erho N
,
Sboner A
,
Schiewer MJ
,
Spratt DE
,
Kothari V
,
Klein EA
et al.
. 2016.
Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.
.
JAMA Oncol. :1-10.
Beltran H
,
Danila D
,
B M
,
Szmulewitz R.
,
Vaishampayan U
,
Armstrong A.
,
Stein M.
,
Hoimes C
,
Pinski J.
,
Scher H.
et al.
. 2016.
A phase 2 study of the aurora kinase A inhibitor alisertib for patients with neuroendocrine prostate cancer (NEPC)
.
2015
Akamatsu S
,
Wyatt AW
,
Lin D
,
Lysakowski S
,
Zhang F
,
Kim S
,
Tse C
,
Wang K
,
Mo F
,
Haegert A
et al.
. 2015.
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.
.
Cell Rep. 12(6):922-36.
2014
Epstein JI
,
Amin MB
,
Beltran H
,
Lotan TL
,
Mosquera J-M
,
Reuter VE
,
Robinson BD
,
Troncoso P
,
Rubin MA
. 2014.
Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.
.
Am J Surg Pathol. 38(6):756-67.
2013
Baca SC
,
Prandi D
,
Lawrence MS
,
Mosquera JMiguel
,
Romanel A
,
Drier Y
,
Park K
,
Kitabayashi N
,
MacDonald TY
,
Ghandi M
et al.
. 2013.
Punctuated evolution of prostate cancer genomes.
.
Cell. 153(3):666-77.
2010
Esgueva R
,
Perner S
,
LaFargue CJ
,
Scheble V
,
Stephan C
,
Lein M
,
Fritzsche FR
,
Dietel M
,
Kristiansen G
,
Rubin MA
. 2010.
Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort.
.
Mod Pathol. 23(4):539-46.
2009
Mosquera J-M
,
Mehra R
,
Regan MM
,
Perner S
,
Genega EM
,
Bueti G
,
Shah RB
,
Gaston S
,
Tomlins SA
,
Wei JT
et al.
. 2009.
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.
.
Clin Cancer Res. 15(14):4706-11.
2007
Cohen RJ
,
Wheeler TM
,
Bonkhoff H
,
Rubin MA
. 2007.
A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma.
.
Arch Pathol Lab Med. 131(7):1103-9.
Perner S
,
Hofer MD
,
Kim R
,
Shah RB
,
Li H
,
Möller P
,
Hautmann RE
,
Gschwend JE
,
Kuefer R
,
Rubin MA
. 2007.
Prostate-specific membrane antigen expression as a predictor of prostate cancer progression.
.
Hum Pathol. 38(5):696-701.
2006
Hofer MD
,
Kuefer R
,
Huang W
,
Li H
,
Bismar TA
,
Perner S
,
Hautmann RE
,
Sanda MG
,
Gschwend JE
,
Rubin MA
. 2006.
Prognostic factors in lymph node-positive prostate cancer.
.
Urology. 67(5):1016-21.
2004
Browne T-J
,
Hirsch MS
,
Brodsky G
,
Welch WR
,
Loda MF
,
Rubin MA
. 2004.
Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.
.
Hum Pathol. 35(12):1462-8.